Join Now

Author Archives: Press Release

POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

Posted in BioUtah News | Tagged | Leave a comment

Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States

Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease

Posted in BioUtah News | Tagged | Leave a comment

Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer

Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer

Posted in BioUtah News | Tagged | Leave a comment

Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding

ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.

Posted in BioUtah News | Tagged | Leave a comment

Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility

Posted in BioUtah News | Tagged | Leave a comment

Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease

Posted in BioUtah News | Tagged | Leave a comment

Fluidx Unveils New Embolic for Neurovascular Use

New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain

Posted in BioUtah News | Tagged | Leave a comment

Nomi Health Hires Global Health and Technology Leader Amy Wykoff as Company’s First Chief Product Officer

Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up delivering Nomi Health’s core business offerings

Posted in BioUtah News | Tagged | Leave a comment

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Science 2022 year-end update

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

Posted in BioUtah News | Tagged | Leave a comment

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

Posted in BioUtah News | Tagged | Leave a comment

NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

Posted in BioUtah News | Tagged | Leave a comment